Ronnie Chamanza
Scientific Director, Pathology Johnson & Johnson
Seminars
Thursday 4th December 2025
Advancing Autologous CAR-T Cell Therapy Development Through Translatable in Vivo Murine Xenograft Tumour Models: A Pathologist’s Perspective
2:30 pm
- Understanding the rationale behind selecting the most relevant and translatable in vivo models
- Leveraging these models to better understand safety and efficacy of CAR-T cells in solid tumours
- Understanding the safety endpoints of the model to advance the clinical translations of this CAR-T therapy
